Results 141 to 150 of about 1,213 (179)

Suppression of Compensatory Erythropoiesis in Hemolytic Disease of the Fetus and Newborn Due to Intrauterine Transfusions [PDF]

open access: yesAmerican Journal of Obstetrics and Gynecology, 2020
BACKGROUND: Infants with severe hemolytic disease of the fetus and newborn often require 1 or multiple intrauterine transfusions to treat fetal anemia. Intrauterine transfusions may have an inhibiting effect on fetal and neonatal erythropoiesis.OBJECTIVE:
Carolien Zwiers   +2 more
exaly   +2 more sources

Hemolytic Disease of the Fetus and Newborn

NeoReviews, 2013
Hemolytic disease of the fetus and newborn (HDFN) is the result of immune-mediated destruction of fetal or newborn red blood cells when such cells contain antigens that are not present in the maternal blood. HDFN is now the preferred term that replaces the historic term erythroblastosis fetalis.
Mary Elizabeth Ross   +3 more
  +4 more sources

The management of hemolytic disease in the fetus and newborn

Seminars in Perinatology, 1997
Rh hemolytic disease (HDN) is the prototype of maternal alloimmunization and fetal hemolytic disease. There are other antigens capable of causing alloimmunization and hemolytic disease such as c, Kell, and Fya. Rh immunization is usually caused by a prior Rh positive fetal maternal transplacental hemorrhage, which occurs in at least 75% of pregnancies.
openaire   +2 more sources

Hemolytic Disease of the Fetus and Newborn Due to Multiple Maternal Antibodies

American Journal of Obstetrics and Gynecology, 2015
The objective of the study was to determine whether women with combinations of red blood cell antibodies are more likely to develop significant hemolytic disease of the fetus and newborn than those with single antibodies.A retrospective exposure cohort study was conducted of pregnant women with red blood cell antibodies.
Haikady N Nagaraja, Karen Q Rossi
exaly   +3 more sources

Hemolytic Disease of the Fetus and Newborn

2016
Hemolytic disease of the fetus and newborn (HDFN) is a condition that results in varying degrees of hyperbilirubinemia and anemia. The diseases that produce this condition are broadly categorized as isoimmune (antibody mediated) or non-isoimmune.
Sara C. Handley, Michael A. Posencheg
openaire   +1 more source

Hemolytic Disease of the Fetus and Newborn

Clinics in Laboratory Medicine, 2021
Melanie E. Jackson, Jillian M. Baker
openaire   +2 more sources

Hemolytic disease of the fetus and newborn in the molecular era

Seminars in Fetal and Neonatal Medicine, 2016
Maternal-fetal red cell antigen incompatibility can lead to alloimmunization, maternal immunoglobulin transplacental transfer, and hemolytic disease of the fetus and newborn (HDFN). The use of routine antenatal anti-D prophylaxis (RAADP) has sharply decreased the incidence of and mortality from HDFN due to RhD allosensitization. The ability to identify
openaire   +2 more sources

Prenatal testing to predict the severity of hemolytic disease of the fetus and newborn

Current Opinion in Hematology, 1996
The severity of hemolytic disease of the fetus or newborn can be assessed with certainty only by measurement of fetal parameters. However, these invasive procedures are not without risk for the fetus. Most erythrocyte antibodies do not cause significant hemolytic disease of the fetus or newborn and various assays are available to assist obstetricians ...
M, Contreras, S F, Garner, M, de Silva
openaire   +2 more sources

HEMOLYTIC DISEASE OF THE FETUS AND THE NEWBORN INFANT

American Journal of Diseases of Children, 1944
The Rh factor of Landsteiner and Wiener1has been shown to be related to about 90 per cent of the reactions to intragroup blood transfusion2and to about 90 per cent of the cases of erythroblastosis (hemolytic disease of the fetus and of the newborn).3 In the typical case, the patient having a hemolytic reaction to an intragroup transfusion or the ...
openaire   +1 more source

Home - About - Disclaimer - Privacy